Ads
related to: what is basal ganglia stroke
Search results
Results From The WOW.Com Content Network
Basal ganglia disease is a group of movement disorders that result from either excessive output from the basal ganglia to the thalamus – hypokinetic disorders, or from insufficient output – hyperkinetic disorders. Hypokinetic disorders arise from an excessive output from the basal ganglia, which inhibits the output from the thalamus to the ...
basilar part of pons, anterior limb or genu of internal capsule, corona radiata, basal ganglia, thalamus, cerebral peduncle The main symptoms are dysarthria and clumsiness (i.e., weakness) of the hand, which often are most prominent when the patient is writing; but dysarthria or involuntary movement can also be seen in legs. [5] Pure sensory stroke
The basal ganglia is a collective group of structures in the brain. These include the striatum, (composed of the putamen and caudate nucleus), globus pallidus, substantia nigra, and the subthalamic nucleus. Along with other structures, the basal ganglia are part of a neural circuit that is integral to voluntary motor function. [1]
For intraparenchymal hemorrhage associated with hypertension, small holes in arteries are thought to cause bleeding in the deep penetrating arteries of the brain, which are smaller and thinner than other arteries. These are the arteries that supply blood to the basal ganglia, the thalamus, the brainstem, and deep portions of the cerebellum ...
Hemiballismus or hemiballism is a basal ganglia syndrome resulting from damage to the subthalamic nucleus in the basal ganglia. [1] It is a rare hyperkinetic movement disorder, [2] that is characterized by pronounced involuntary limb movements [1] [3] on one side of the body [4] and can cause significant disability. [5]
Anatomical overview of the main circuits of the basal ganglia. Subthalamic nucleus is shown in red. Picture shows 2 coronal slices that have been superimposed to include the involved basal ganglia structures. + and - signs at the point of the arrows indicate respectively whether the pathway is excitatory or inhibitory in effect.